According to Stratistics MRC, the Global Continuous Renal Replacement Therapy (CRRT) Market is accounted for $0.78 billion in 2015 and is expected to reach $1.26 billion by 2022 growing at a CAGR of 7.1%. The clinical advantages of CRRT Techniques are the primary factors favoring the market growth. Furthermore, rapidly increasing aging population, rising number of Acute Kidney Injury (AKI) patients and technological advancements & new product launches are the factors influencing the market growth. However, high complexity & procedural costs of CRRT therapy, inconsistent reimbursement scenario in European countries and lack of trained ICU nurses are the factors restraining the market growth.
Check the Discount on this report @ http://www.orbisresearch.com/contacts/discount/184629 .
In 2015, dialysate and replacement fluids segment has the dominant share in global Continuous Renal Replacement Therapy (CRRT) products market and is expected to continue its dominance throughout the forecast period. The dominance is due to its higher demand during CRRT procedure, and improvisation and commercialization of advanced renal replacement solutions. Based on modality, Continuous Venovenous Hemofiltration (CVVH) segment has the leading market share in 2015 and Continuous Venovenous Hemodiafiltration (CVVHDF) segment is expected to witness high growth rate.
Europe has the largest regional market for Continuous Renal Replacement Therapy (CRRT) due to approval of CRRT machine and anti-coagulants for multiple applications, rapidly increasing aging population and increasing prevalence of AKI patients. Asia Pacific is expected to witness highest growth on account of rapidly expanding healthcare infrastructure in emerging markets such as India and China.
Some of the key players in the global Continuous Renal Replacement Therapy (CRRT) market include Infomed SA, Toray Medical Company Limited, Baxter International, Asahi Kasei Medical Co., Ltd., Medica S.P.A., Medical Components, Inc., NikkisCo., Ltd., Covidien, Fresenius Medical Care AG & Co. KGaA, NxStage Medical, Inc., BellcS.R.L. and B. Braun Melsungen AG.
Request a sample of this report @ http://www.orbisresearch.com/contacts/request-sample/184629 .
Dialysate and Replacement Fluids
Rest of Europe
Rest of Asia Pacific
Rest of the World
What our report offers:
– Market share assessments for the regional and country level segments
– Market share analysis of the top industry players
– Strategic recommendations for the new entrants
– Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
– Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
– Strategic recommendations in key business segments based on the market estimations
– Competitive landscaping mapping the key common trends
– Company profiling with detailed strategies, financials, and recent developments
– Supply chain trends mapping the latest technological advancements
Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.
Senior Manager – Client Engagements
4144N Central Expressway,
Suite 600, Dallas,
Texas – 75204, U.S.A.
Phone No.: +1 (214) 884-6817; +912064101019
Email ID: email@example.com